Measles cases in Texas, New Mexico rise to 294 as outbreak spreads
Measles cases in Texas and New Mexico rose to 294 on Friday, surpassing all U.S. cases recorded in 2024, as an outbreak that began in late January in West Texas spreads.
Measles cases in Texas and New Mexico rose to 294 on Friday, surpassing all U.S. cases recorded in 2024, as an outbreak that began in late January in West Texas spreads.
Texas and New Mexico on Tuesday reported an increase of 28 cases of measles in the last five days, bringing the total known infections to 256 in the two states since an
Texas and New Mexico on Friday reported an additional 59 cases of measles for a total of 228 known infections in those states, where an outbreak that began in West Texas in
A New Mexico resident who has died, tested positive for measles, the state health department said on Thursday, marking the second measles-related
India is ready to step in as an alternative site for early-stage clinical trials to help mitigate the impact of disruptions such as the Russia
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of
A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the month has been postponed,
The U.S.
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, clinical trial experts and doctors
Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about
Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as it aims to show investors
Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter revenues and profit above Wall
Johnson & Johnson on Tuesday reported quarterly results just above Wall Street expectations, helped by strong sales of its blockbuster psoriasis drug
About 75,000 medical workers from Kaiser Permanente facilities went on a planned three-day strike on Wednesday, putting pressure on one of the leading not-
UnitedHealth reported a third-quarter profit on Friday ahead of analysts' estimates, helped by a lower-than-feared rise in medical costs at the company's
Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter medical devices
Pfizer on Tuesday urged investors to focus on growth in non-COVID products such as the new RSV vaccine Abrysvo as slumping demand for COVID-19 vaccines
Novo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by their
Retail flows into Eli Lilly spiked to a more than two-year high in November, as small investors rushed to buy the stock after the U.S. pharma major
Weight loss was the talk of this earnings season, making names such as Wegovy, Ozempic and Mounjaro the water-cooler discussion that companies across
AbbVie's decision to buy Cerevel Therapeutics before key data on the drug developer's experimental schizophrenia treatment may have helped it avoid a
Eli Lilly on Tuesday forecast 2024 profit above Wall Street estimates on soaring demand for Zepbound, its recently approved weight-loss drug, and said
Americans are catching up on healthcare missed during the COVID-19 pandemic, a trend driven by heart procedures and outpatient orthopedic surgeries that
Fertility rates in nearly all countries will be too low to sustain population levels by the end of the century, and most of the world's live births will be occurring in
Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise its annual sales forecast by
Your subscription includes
Unlimited Access to All Content from
The Los Angeles Post
Your subscription has been successfully upgraded!